SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-034514
Filing Date
2022-02-10
Accepted
2022-02-10 16:29:56
Documents
4
Group Members
LILLY VENTURES FUND I LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d309389dsc13ga.htm SC 13G/A 56591
2 EX-99.1 d309389dex991.htm EX-99.1 6205
3 EX-99.2 d309389dex992.htm EX-99.2 4905
4 EX-99.3 d309389dex993.htm EX-99.3 4778
  Complete submission text file 0001193125-22-034514.txt   74471
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filed by) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472
Business Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Subject) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91541 | Film No.: 22614424
SIC: 2836 Biological Products, (No Diagnostic Substances)